My bioparkWELCOME TO BIOPARK
What's in
the news ?
RUE ClÉMENT ADER, 10 6041 CHARLEROI
+32 71 91 99 50
News
Back
European Investment Bank provides Minoryx with up to €25 million to support development of breakthrough therapies in orphan neurodegenerative diseases
October 30th 2020
BioPark
- EIB support to develop breakthrough treatments to address orphan neurodegenerative diseases with high unmet medical needs
- Focus on Minoryx’s lead asset, leriglitazone, a novel, disease-modifying PPAR-γ agonist
- Venture debt operation supported by the Investment Plan for Europe
Please discover the press release here.